Clinical Trial: Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics: Efficacy Study in Adults and Children. Randomized Prospective Study With Direct Individual Benefit
Brief Summary: This study will evaluate the benefit of lidocaine perfusion in cancer related visceral pain resistant to morphinics. It is an efficacy study in adults and children and a randomized prospective study.
Detailed Summary:
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Current Primary Outcome: To determine prospectively the lidocaine efficacy in 2 types of patient populations with cancer (group A: children from 6 to 14 years old and group B: adults from 15 to 70 years old) [ Time Frame: continuous intravenous perfusion for 6 days ]
Original Primary Outcome: To determine prospectively the lidocaine efficacy (continuous intravenous perfusion during 6 days) in 2 types of patient population with cancer (group A: children from 6 to 14 years old and group B : adults from 15 to 70 years old)
Current Secondary Outcome: To confirm the tolerance of the lidocaine
Original Secondary Outcome: Same as current
Information By: Gustave Roussy, Cancer Campus, Grand Paris
Dates:
Date Received: September 13, 2005
Date Started: May 2005
Date Completion:
Last Updated: September 18, 2007
Last Verified: September 2006